Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

  • receive the eCopy two days prior to the printed edition.
  • can partake in our online MCQs.
  • can enter our online sports quiz. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

Possible sildenafil reclassification in Ireland

By Mindo - 10th Jan 2018 | 45 views

“Pfizer is exploring a number of opportunities to expand access to medications via reclassification to non-prescription status,” a spokesperson for the company told the <strong><em>Medical Independent</em></strong> (<strong><em>MI</em></strong>).

In the UK, Viagra Connect tablets are being reclassified as a non-prescription pharmacy medicine for the treatment of the symptoms of ED in men aged 18 years and over.

“The benefits of making Viagra Connect available to men with ED are not limited to the UK market and we are exploring other markets where this may be possible,” a Pfizer spokesperson told <strong><em>MI</em></strong> when asked whether it is considering making an application for Viagra to be reclassified in Ireland.

The Health Products Regulatory Authority (HPRA) told <strong><em>MI</em></strong> that it is not in a position to say whether it has received any application to change the current prescription-only classification of sildenafil to make it available OTC “due to commercial sensitivities”.

“The HPRA welcomes applications for innovative reclassifications, and provides guidance on its website,” the HPRA spokesperson told <strong><em>MI</em></strong>.

Counterfeit and illegal ED drugs are among the most common detained medicinal products by the HPRA and Customs every year and supporters of reclassifying sildenafil say making it available OTC could help alleviate the issue.

Leave a Reply

Latest Issue
medical news
The Medical Independent 19th May 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read